Expanding the clinical trial portfolio for lung cancer
What should uro-oncologist know about new drugs in 2017?
Novel treatments in muscle invasive and non-muscle invasive bladder cancer
Hendrik Van Poppel
Data update in advanced stage NSCLC
SECOMBIT – determining the order of sequential therapies in metastatic melanoma with BRAF mutations